Constellation Pharmaceuticals Inc (CNST)
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology
Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma PLANEGG / MUNICH, GERMANY / ACCESSWIRE / July 15, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR) ("MorphoSys") today announced the successful completion of its previously announced cash tender offer for all outstanding shares of Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) ("Constellation") for $34.00 per share, net to
Interesting CNST Put Options For August 20th
A Buy the Dip Stock Trigger in Constellation Pharmaceuticals Inc
The Techncial Trigger Driven Stock Trade in Constellation Pharmaceuticals Inc (NASDAQ:CNST) .
INVESTIGATION ALERT: Halper Sadeh LLP Investigates IKNX, MPB, JAX, CNST; Shareholders are Encouraged to Contact the Firm
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals
MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), for its tender offer for Constellation Pharmaceuticals, Inc., (NASDAQ:CNST) ("Constellation"). The expiration of the HSR waiting period satisfies one of the conditions to the tender offer, which is
Lifshitz Law Firm, P.C. Announces Investigation of CNST, FFWM, SLCT, and GRA
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates CORE, MMAC, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 28, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Core-Mark Holding Company, Inc. (NASDAQ:CORE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Performance Food Group Company. Under the terms of the merger, Core-Mark shareholders will receive $23.875 per share in cash and
INVESTIGATION ALERT: Halper Sadeh LLP Investigates EBSB, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Meridian Bancorp, Inc. (NASDAQ:EBSB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Independent Bank Corp. Under the terms of the agreement, Meridian Bancorp stockholders will receive 0.2750 of a share of Independent Bank
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - CORE, MMAC, FMBI, CNST, SLCT
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to MorphoSys AG for $34.00 per share in cash. If you are a Constellation shareholder, click here to learn more about your
INVESTOR ALERT: Monteverde & Associates Continues to Investigate the Following Merger
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of CNST, USCR, SVBI, and QTS Buyouts
Biogen's FDA Win Marks a Mini-Rally in Biotech Stocks
Biotech stocks are surging in June on a raft of upbeat news from Biogen. It's a turnaround from a spring drubbing.
Lifshitz Law Firm, P.C. Announces Investigation of CNST, EQT, FFWM, TGRF, MDP, MMAC, QTS, SLCT, FBNC, USCR
Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DSSI, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 10, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Diamond S Shipping Inc. (NYSE:DSSI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to International Seaways, Inc. Under the merger agreement, Diamond S shareholders will receive 0.55375 shares of International Seaways common
Moore Kuehn Encourages USCR, QTS, CNST and ESXB Investors to Contact Law Firm
J.P. Morgan Downgrades Constellation Pharmaceuticals (CNST) to Hold
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Constellation Pharmaceuticals, Inc. - CNST
The Top-Returning IPOs of the Pandemic
A biotech. A shipper. A sporting goods chain. A home builder. There are many paths to IPO success.
Lifshitz Law Firm, P.C. Announces Investigation of ESXB, UBSI, CNST, MOR, EQT, FFWM, TGRF, MDP, MMAC, SLCT, FBNC, and SWN
Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting
Why MorphoSys Stock Sank This Week
Investors weren't happy about the drugmaker's wheeling and dealing.
Why Constellation Pharmaceuticals Stock Was Crushing It This Week
The small drugmaker is being acquired by MorphoSys.
CONSTELLATION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CNST and Encourages Investors to Contact the Firm
MorphoSys Fell Too Far After M&A News, Analyst Says
SVB Leerink's Geoffrey Porges says the purchase of Constellation Pharmaceuticals makes strategic sense.